Best Compounds for Sexual Health: Evidence-Based Rankings
Sexual health is a fundamental aspect of overall wellbeing and quality of life, yet it remains understudied in mainstream medicine. When sexual dysfunction occurs—whether manifesting as low libido, erectile dysfunction, reduced fertility, or diminished arousal—the impact extends beyond physical health into emotional and relational wellbeing.
While pharmaceutical interventions exist for some sexual health concerns, many individuals seek evidence-based alternatives or complementary approaches. The supplement and peptide markets are saturated with claims, but distinguishing between marketing hype and genuine clinical efficacy requires rigorous examination of human research data.
This article ranks compounds for sexual health based on the strength of human clinical evidence, providing specific findings from peer-reviewed studies, typical dosing protocols, and estimated costs. The rankings follow a tiered system where Tier 4 represents the strongest evidence and lower tiers represent more preliminary findings.
Why Evidence-Based Supplementation Matters
Sexual dysfunction affects approximately 40% of women and 30% of men at some point in their lives. Before considering supplementation, understanding the evidence quality is essential. Some compounds demonstrate clinically meaningful improvements in multiple randomized controlled trials (RCTs), while others show promise in preliminary studies but lack independent replication.
This ranking system prioritizes:
- Human research data over animal studies
- Randomized controlled trials over observational studies
- Replication across independent research groups
- Clinically meaningful effect sizes, not just statistical significance
- Safety profiles and adverse event documentation
Tier 4: Strongest Evidence
Ashwagandha (Supplement)
What it is: Ashwagandha (Withania somnifera) is an adaptogenic herb from traditional Ayurvedic medicine that modulates stress hormones and supports reproductive function.
Evidence summary: Ashwagandha demonstrates consistent improvements across multiple human RCTs in male sexual function, semen parameters, and sexual satisfaction. The evidence is strong, though sample sizes remain modest.
Key finding: In a 90-day RCT of 46 oligospermic men, ashwagandha at 675 mg/day increased sperm count by 167% (from 9.59 to 25.61 million/mL, p<0.0001). Placebo showed minimal change.
Typical dosing: 300-600 mg daily (usually standardized to 5% withanolides)
Estimated cost: $15-40/month
Considerations: Effects appear stronger for men with low baseline testosterone or infertility concerns. Long-term safety data beyond 12 months is limited.
PT-141 (Bremelanotide) (Peptide)
What it is: PT-141 is a melanocortin receptor agonist peptide developed specifically for sexual desire and arousal disorders in women.
Evidence summary: Multiple well-designed Phase 3 RCTs demonstrate consistent improvements in sexual desire and arousal in premenopausal women with hypoactive sexual desire disorder. This is the only FDA-approved medication for female sexual desire disorder.
Key finding: The RECONNECT trials (n=1,202) showed bremelanotide increased the FSFI-desire domain by 0.35 points versus placebo (p<0.001) and significantly reduced sexual distress across all demographic subgroups.
Typical dosing: 1.75 mg subcutaneous injection 45 minutes before sexual activity (marketed as Vyleesi)
Estimated cost: $500-1,000 per month (with insurance; without, $1,300+/injection)
Considerations: Most common adverse effects are nausea (40%) and flushing (15%). Not recommended for women with uncontrolled hypertension. Requires subcutaneous injection.
CoQ10 (Supplement)
What it is: Coenzyme Q10 is an essential mitochondrial cofactor that supports cellular energy production and acts as a potent antioxidant, particularly relevant for sperm health and egg quality.
Evidence summary: Robust evidence from multiple meta-analyses and 16+ RCTs demonstrates CoQ10's efficacy for sperm quality, female fertility markers, and pregnancy rates. Effects are consistent across independent studies.
Key finding: Network meta-analysis of 16 RCTs found CoQ10 increased sperm concentration more than other antioxidants (standardized mean difference 2.98 [95% CI: 1.13-7.87]).
Typical dosing: 200-600 mg daily (ubiquinol form may be better absorbed than ubiquinone)
Estimated cost: $20-50/month
Considerations: Particularly effective for male factor infertility and may benefit women undergoing fertility treatment. Effects typically appear after 3-6 months of consistent use.
Fenugreek (Supplement)
What it is: Fenugreek (Trigonella foenum-graecum) is a legume with active compounds including furostanol saponins that support testosterone production and sexual function.
Evidence summary: Multiple human RCTs demonstrate clinically meaningful improvements in sexual function and testosterone levels in both men and women, with consistent positive effects on libido and sexual arousal.
Key finding: In a 12-week study (n=50), Furosap (standardized fenugreek extract) increased free testosterone by 46% in 90% of the male study population.
Typical dosing: 300-600 mg daily (standardized extracts like Furosap contain 50% saponins)
Estimated cost: $15-35/month
Considerations: May have a mild maple-like odor in sweat and urine. Effects typically appear within 2-4 weeks.
Pycnogenol (Supplement)
What it is: Pycnogenol is a standardized extract of French maritime pine bark rich in proanthocyanidins and phenolic compounds that improve nitric oxide availability and vascular function.
Evidence summary: When combined with L-arginine, pycnogenol demonstrates consistent efficacy for erectile dysfunction and sexual dysfunction across multiple RCTs. Effect sizes are clinically meaningful.
Key finding: In a 6-month RCT (n=124), the combination product Prelox improved IIEF erectile domain scores from baseline 15.2 to 27.1, compared to placebo improvement to 19.0 (p<0.05).
Typical dosing: 80-120 mg pycnogenol daily, often combined with 1.5-3g L-arginine
Estimated cost: $30-60/month for combination products
Considerations: Most effective for mild to moderate erectile dysfunction. Requires consistent use for 2-3 months before maximal benefit. Generally well-tolerated.
Tier 3: Probable Evidence
Thymosin Alpha-1 (Peptide)
What it is: Thymosin alpha-1 is an immunomodulatory peptide that enhances immune function and reproductive health markers, particularly in infertile men.
Evidence summary: One multicenter RCT demonstrates meaningful improvements in sperm fertilizing capacity in infertile men. Evidence is limited to male infertility without independent replication.
Key finding: In infertile men (n=68), thymosin alpha-1 increased sperm fertilizing capacity by 31-45% in 76% of subjects (p=0.0006 to <0.0001).
Typical dosing: 1.6 mg subcutaneous injection, 2-3 times weekly for 12 weeks
Estimated cost: $80-150/month
Considerations: Requires prescription and medical supervision. Specific benefit appears limited to men with impaired sperm fertilizing capacity.
Kisspeptin (Peptide)
What it is: Kisspeptin is a neuropeptide that stimulates the reproductive hormone cascade by activating GnRH neurons, studied via intranasal delivery.
Evidence summary: One positive human RCT demonstrates rapid gonadotropin release via intranasal kisspeptin. Evidence remains limited to a single trial with modest sample sizes; broader clinical validation is needed.
Key finding: Intranasal kisspeptin-54 (12.8 nmol/kg) rapidly stimulated LH release with mean increases of 4.4 ± 0.6 IU/L above baseline in healthy adults and patients with hypothalamic amenorrhea, with no adverse events.
Typical dosing: 12.8 nmol/kg intranasal (clinical application still in research phase)
Estimated cost: Not commercially available; research-only
Considerations: Extremely preliminary stage. Clinical applications and commercial availability are years away. Included for completeness regarding emerging research.
Melanotan 2 (Peptide)
What it is: Melanotan II is a synthetic melanocortin receptor agonist that stimulates sexual desire and can induce erections through melanocortin-4 receptor activation.
Evidence summary: Three small RCTs show consistent positive results for erectile dysfunction and sexual desire, but evidence is limited by small sample sizes (n=10-20), short duration, and lack of independent replication. Serious adverse events have been documented.
Key finding: In men with psychogenic ED (n=10), melanotan II at 0.025 mg/kg induced clinically apparent erections in 8/10 men versus none with placebo. Mean tip rigidity >80% duration was 38 minutes versus 3 minutes for placebo (p=0.0045).
Typical dosing: 0.025 mg/kg subcutaneous injection
Estimated cost: $50-150/month (underground market; not FDA-approved)
Considerations: Serious adverse events including priapism and systemic toxicity have been documented. Not approved for human use in most countries. Significant safety concerns warrant caution.
Gonadorelin (Peptide)
What it is: Gonadorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist that stimulates the pituitary-gonadal axis to increase testosterone and gonadotropin production.
Evidence summary: Mixed results across different clinical scenarios. Demonstrates probable efficacy for fertility-related outcomes in assisted reproductive technology and cryptorchidism treatment, but lacks large RCTs specifically focused on sexual function.
Key finding: Network meta-analysis of 36 RCTs showed GnRH agonist monotherapy improved pregnancy odds versus placebo in endometriosis-related infertility (OR 1.68, 95% CI 1.07-2.46).
Typical dosing: 100-500 μg subcutaneous or intranasal daily
Estimated cost: $100-300/month
Considerations: Clinical utility is primarily in assisted reproduction and specific medical conditions. Effects on general sexual function are less well-established.
Prostatilen (Peptide)
What it is: Prostatilen is a peptide extract derived from prostate tissue that supports spermatogenesis and prostate function.
Evidence summary: Multiple observational studies and 2 RCTs show probable efficacy for spermatogenesis, but evidence is limited by small sample sizes, short treatment durations, and lack of independent replication.
Key finding: In men with impaired sperm parameters (n=98), Prostatilen AC increased total motile spermatozoa by 14.3% versus 4.1% for standard Prostatilen after 10 days (RCT).
Typical dosing: 10-50 mg daily (various formulations)
Estimated cost: $40-100/month
Considerations: More commonly used in Russian and Eastern European medicine. Limited research outside these regions. Best suited for men with specific prostate-related sexual health concerns.
Omega-3 Fatty Acids (Supplement)
What it is: Omega-3 polyunsaturated fatty acids (EPA and DHA) from fish oil or algae support vascular health, reduce inflammation, and support reproductive function.
Evidence summary: Consistent positive associations in observational studies and some RCT support for female fertility and semen quality. Evidence remains limited by small sample sizes, short durations, and lack of large-scale randomized trials.
Key finding: In a prospective cohort of 900 women across 2,510 cycles, omega-3 supplementation was associated with increased fecundability (higher probability of natural conception per cycle).
Typical dosing: 1,000-3,000 mg daily (combined EPA and DHA)
Estimated cost: $10-30/month
Considerations: Particularly beneficial for individuals with low omega-3 status or cardiovascular risk factors. Effects on fertility may be strongest in women with suboptimal baseline intake.
NAC (N-Acetylcysteine) (Supplement)
What it is: NAC is a precursor to glutathione, the body's primary intracellular antioxidant, supporting sperm health and reproductive tissue function.
Evidence summary: Multiple human RCTs demonstrate probable efficacy for male infertility and PCOS-related female infertility, but evidence is limited by small sample sizes, inconsistent results in some populations, and lack of replication.
Key finding: In men with infertility (n=50), NAC 600 mg/day for 3 months significantly increased sperm motility and concentration while decreasing DNA fragmentation and abnormal morphology.
Typical dosing: 600-1,200 mg daily (usually in 2-3 divided doses)
Estimated cost: $15-30/month
Considerations: Most useful for male factor infertility. In women, primarily studied for PCOS-related reproductive issues. Generally well-tolerated.
Vitamin D3 (Supplement)
What it is: Vitamin D3 (cholecalciferol) is a fat-soluble steroid hormone critical for reproductive health, immune function, and sexual desire.
Evidence summary: Probable efficacy for sexual health, particularly in women with deficiency. Multiple studies show improvements in sexual function scores and fertility markers. Evidence is limited by small sample sizes and inconsistent results in male fertility.
Key finding: Women with sexual dysfunction and vitamin D deficiency (n=76) showed FSFI score improvement from 16.3 to 25.0 after vitamin D3 therapy (300,000 IU IM at baseline and week 4), sustained at week 8 (p<0.001).
Typical dosing: 1,000-4,000 IU daily (or 10,000-50,000 IU weekly; target serum level 30-50 ng/mL)
Estimated cost: $8-20/month
Considerations: Check baseline vitamin D status before supplementing. Effects appear strongest in deficient populations. Benefits may be sex-specific (stronger in women).
Zinc (Supplement)
What it is: Zinc is an essential mineral critical for testosterone production, immune function, and sperm health.
Evidence summary: Mixed evidence. Shows modest benefits in small RCTs of subfertile men and some populations, but a large RCT found no improvement in live birth rates or major semen parameters. Evidence is inconsistent across studies.
Key finding: In the FAZST trial (n=2,370), folic acid 5 mg + zinc 30 mg daily for 6 months showed NO significant difference in live birth rates, sperm concentration, motility, or morphology versus placebo.
Typical dosing: 30-50 mg daily (as zinc glucinate or picolinate)
Estimated cost: $8-15/month
Considerations: May be beneficial only in zinc-deficient individuals. High-dose supplementation can impair copper absorption. General population likely derives minimal benefit.
Berberine (Supplement)
What it is: Berberine is an alkaloid compound from plants like barberry and goldenseal that improves insulin sensitivity, inflammation, and hormonal balance.
Evidence summary: Probable efficacy for PCOS-related sexual and reproductive health with two RCTs demonstrating improvements in menstrual regularity and ovarian morphology. Evidence is limited to PCOS populations without independent replication.
Key finding: Berberine Phytosome 550 mg twice daily for 90 days restored regular menstruation in 70% of PCOS women versus 16% in controls (n=130, p<0.0001).
Typical dosing: 500-1,500 mg daily (in 2-3 divided doses; phytosome forms may have better absorption)
Estimated cost: $20-45/month
Considerations: Specifically indicated for PCOS-related sexual dysfunction or infertility. Minimal evidence in non-PCOS populations. GI side effects are common initially.
How to Choose the Right Compound
1. Identify Your Primary Concern
For erectile dysfunction: Pycnogenol + L-arginine, ashwagandha, or melanotan II (if willing to accept risk profile)
For low sexual desire: PT-141 (women), fenugreek, ashwagandha
For female sexual dysfunction: Vitamin D3 (if deficient), PT-141, omega-3
For infertility/subfertility: CoQ10, ashwagandha, NA